|
|
|
|
|
| |
Boston Scientific Bids To Acquire Guidant For $25 B |
|
| |
1:18 PM EST January 09 2006 |
|
|
| |
Boston Scientific Corp. ((BSX)) said it formally bid to acquire Guidant Corp. ((GDT)) for $25 billion. The purchasing price includes $36 in cash and $36 in Boston Scientific stock, or $72 a share, the same terms it had proposed in an informal bid made on Dec. 5. Boston Scientific also revealed details of its formal bid for Guidant, which it said represented a 12% premium over the price offered by existing merger partner, Johnson & Johnson. |
|
|
| |
|
|
|
